IGF1 and cancer: In view of our results showing previously unrecognized links between the IGF1 axis and a series of metabolic (and other) genes that are differentially represented in a rare condition associated with cancer protection, we propose that at least some of these genes may constitute novel biomarkers capable of predicting and/or monitoring responses to anti-IGF1R therapy [90].